Press release
Companion Diagnostics (CDx) Development Market to Surpass USD 26.4 Billion by 2034
Companion Diagnostics (CDx) Development
Pune, India, November 2025 - According to Exactitude Consultancy, the Global Companion Diagnostics (CDx) Development Market is projected to reach USD 26.4 billion by 2034, growing at a CAGR of 13.7% from 2025 to 2034. The rapid evolution of personalized medicine, coupled with increasing integration of genomic testing and AI-driven analytics into pharmaceutical R&D, is transforming the way therapies are designed, approved, and prescribed.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73474
Companion diagnostics are laboratory-based tests that determine the suitability of a patient for specific drug therapies, often by detecting predictive biomarkers. Their growing use in oncology, neurology, and immunology has made them an essential component of precision healthcare strategies.
Key Takeaways
• Market Size: USD 7.9 billion in 2024 → projected USD 26.4 billion by 2034
• CAGR: 13.7% (2025-2034)
• Primary Growth Drivers: Expansion of precision oncology, growth in targeted therapies, and regulatory support for co-developed diagnostics
• Top Companies: Roche Diagnostics, Thermo Fisher Scientific, Agilent Technologies, Qiagen N.V., Abbott Laboratories, Illumina Inc., Guardant Health, BioMérieux, and Foundation Medicine
• Leading Regions: North America holds 41% market share; Asia-Pacific shows fastest CAGR (Less than 15%)
Market Story
The companion diagnostics market is evolving rapidly as pharmaceutical companies increasingly integrate biomarker identification into drug discovery pipelines. Nearly 60% of new oncology drugs approved by the FDA in 2024 were accompanied by a companion diagnostic test.
Major players such as Roche and Thermo Fisher are leading the development of next-generation sequencing (NGS)-based CDx assays for cancer mutations (EGFR, ALK, KRAS, and BRAF). Simultaneously, AI-powered algorithms are enhancing biomarker discovery, enabling early detection of therapy response and resistance patterns.
Beyond oncology, companion diagnostics are now expanding into autoimmune, cardiovascular, and infectious disease applications, as precision medicine becomes a core element of global healthcare policy.
Market Segmentation
By Technology:
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• Immunohistochemistry (IHC)
• In Situ Hybridization (ISH)
• Flow Cytometry
• Others (Mass Spectrometry, AI-based Platforms)
By Indication:
• Oncology
• Neurology
• Infectious Diseases
• Autoimmune Disorders
• Cardiovascular Diseases
By End User:
• Pharmaceutical & Biotechnology Companies
• Reference Laboratories
• Hospitals & Academic Medical Centers
By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/73474/companion-diagnostics-cdx-development-market
Recent Developments
• October 2025: Roche Diagnostics launched a new FoundationOne® Liquid CDx assay expansion for multi-gene cancer profiling in Europe.
• August 2025: Thermo Fisher Scientific introduced its Oncomine Precision Assay GX, a next-gen sequencing platform co-developed with AstraZeneca for global clinical use.
• June 2025: Illumina Inc. announced a partnership with Pfizer to develop RNA-based companion diagnostics for immunotherapy response monitoring.
• May 2025: Agilent Technologies expanded its Dako PD-L1 IHC 28-8 pharmDx companion test portfolio to include new solid tumor indications.
• March 2025: Guardant Health received FDA approval for Guardant360® CDx as a liquid biopsy test for multiple cancer types.
Expert Insight
"The future of drug development lies in biomarker-driven decision-making," said Dr. Evelyn Carver, Senior Diagnostics Analyst at Exactitude Consultancy. "Companion diagnostics are now indispensable for optimizing therapeutic efficacy and reducing adverse effects, marking a fundamental shift toward truly personalized medicine."
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73474
Market Drivers
• Increasing co-development of targeted drugs and diagnostics by pharma companies
• Rising number of oncology clinical trials incorporating biomarker testing
• Expanding applications of NGS and AI in multi-omics profiling
• Favorable regulatory frameworks from FDA, EMA, and PMDA supporting simultaneous drug-CDx approval
Forecast and Regional Outlook
North America dominates the global market due to advanced molecular diagnostic infrastructure, early adoption of CDx-integrated clinical trials, and high cancer incidence. Europe follows with increasing investment in multi-country genomic medicine programs and reimbursement reforms for biomarker testing.
Asia-Pacific is forecast to post the fastest CAGR (Less than 15%), driven by precision oncology initiatives, growing biotechnology hubs, and increased accessibility of molecular testing in countries like China, Japan, and South Korea.
Government & Institutional Initiatives
• U.S. FDA expanded its Breakthrough Devices Program to accelerate CDx test approvals.
• European Commission's Horizon Europe Program launched funding for AI-driven biomarker discovery collaborations.
• Japan's PMDA issued new guidelines for co-approval of companion diagnostics with targeted drugs.
• China's NMPA introduced a national strategy for genomic data integration under the Precision Medicine Initiative 2030.
Conclusion
The Companion Diagnostics Development Market stands at the forefront of healthcare's precision revolution. As collaboration between pharmaceutical, biotech, and diagnostic firms intensifies, CDx will play a pivotal role in ensuring targeted, efficient, and safe therapeutic interventions-transforming global patient care and clinical outcomes over the next decade.
This report is also available in the following languages : Japanese (コンパニオン診断(CDx)開発市場), Korean (동반 진단(CDx) 개발 시장), Chinese (伴随诊断(CDx)开发市场), French (Marché du développement des tests compagnons (CDx)), German (Markt für Begleitdiagnostik (CDx)), and Italian (Sviluppo del mercato della diagnostica di accompagnamento (CDx)), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/73474/companion-diagnostics-cdx-development-market#request-a-sample
Related Reports
Medical Laser Film Market
https://exactitudeconsultancy.com/reports/75935/medical-laser-film-market
Medical Micropump Market
https://exactitudeconsultancy.com/reports/75975/medical-micropump-market
Male Infertility Market
https://exactitudeconsultancy.com/reports/76031/male-infertility-market
Next-Generation Sequencing (NGS) Market
https://exactitudeconsultancy.com/reports/76042/next-generation-sequencing-ngs-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostics (CDx) Development Market to Surpass USD 26.4 Billion by 2034 here
News-ID: 4257492 • Views: …
More Releases from Exactitude Consultancy
Oriented Perforating System Market Expands as Oil & Gas Producers Demand 2034
Sub-headline: Growing investments in directional drilling, unconventional reservoirs, and high-precision well stimulation technologies are driving the oriented perforating system market through 2034.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/75135
Introduction
The global Oriented Perforating System Market is witnessing strong growth as oil & gas operators prioritize precision perforation to maximize reservoir productivity, reduce formation damage, and enhance wellbore connectivity. Oriented perforating systems-engineered to align perforation tunnels toward the optimal reservoir direction-are…
Automotives Infrared Cores Market Accelerates as ADAS, Night Vision Systems, and …
Sub-headline: Growing demand for thermal imaging, enhanced driver assistance systems, and smart safety features is fueling strong growth in the automotive infrared cores market through 2034.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/75133
Introduction
The global Automotives Infrared Cores Market is witnessing rapid expansion as vehicles increasingly adopt advanced infrared imaging technologies to improve visibility, safety, and autonomous navigation. Infrared cores-compact thermal imaging modules integrated into ADAS, night vision systems, pedestrian…
Safeguards for Passenger Transfer Area Market Grows 2034
Sub-headline: Increasing global investments in public transport infrastructure, rising passenger traffic, and growing focus on automated safety systems are driving the safeguards for passenger transfer area market through 2034.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/75131
Introduction
The global Safeguards for Passenger Transfer Area Market is witnessing significant growth as transport authorities, airports, metro stations, and bus terminals enhance safety, accessibility, and operational efficiency in high-traffic areas. Safeguards-such as platform screen…
Titanium Catalyst for Polyester Market Expands ,Demand Increases Globally
Sub-headline: Rising PET bottle production, sustainability-driven adoption of eco-friendly catalysts, and advances in high-purity polyester processing are driving strong growth in the titanium catalyst for polyester market through 2034.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/75129
Introduction
The global Titanium Catalyst for Polyester Market is witnessing steady expansion as manufacturers shift from antimony-based catalysts to titanium-based alternatives for safer, cleaner, and more efficient polyester production. Titanium catalysts are preferred for PET…
More Releases for CDx
Global Pharmacogenomics Technology Theranostics CDx Outlook Market Analysis (202 …
LPI (LP Information)' newest research report, the "Pharmacogenomics Technology Theranostics CDx Outlook Industry Forecast" looks at past sales and reviews total world Pharmacogenomics Technology Theranostics CDx Outlook sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmacogenomics Technology Theranostics CDx Outlook sales for 2025 through 2031. With Pharmacogenomics Technology Theranostics CDx Outlook sales broken down by region, market sector and sub-sector, this report provides a…
Pharmacogenomics Technology (Theranostics & CDx) market size ascends with a CAGR …
The global Pharmacogenomics Technology (Theranostics & CDx) market size was valued at USD 9869.6 million in 2022 and is forecast to a readjusted size of USD 24800 million by 2029 with a CAGR of 14.1% during review period. The global Pharmacogenomics Technology market has witnessed remarkable growth in recent years, driven by advancements in genetic research, personalized medicine, and the increasing demand for targeted therapies. Pharmacogenomics, the study of how…
Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Over …
The Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) market report is a perfect foundation for people looking out for a comprehensive study and analysis of the Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) market. On the basis of historic growth analysis and current scenario of Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) market place, the report intends to offer actionable insights and outlook on global / regional market growth projections. Authenticated data presented in report is based on findings…
Pharmacogenomics Technology Or Theranostics Or Companion Diagnostics (CDx) Marke …
The market study contains demand, application information, price trends, historical and projected market data, company shares of the top Pharmacogenomics Technology Or Theranostics Or Companion Diagnostics (CDx) providers by region. According on application type, geography, and market size (by volume and value), the report segments the market. This report's main goal is to aid the reader in understanding the market in terms of its definition, segmentation, market potential, significant trends,…
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market …
The Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Pharmacogenomics Technology…
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market …
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market survey report has been prepared by conducting market research in a…
